FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

427048007: Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2662930013 Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    2674863017 Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    330841000077116 Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable Is a vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite, l'hépatite B (recombinant) et Haemophilus influenzae de type B (recombinant) false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin recombinant contre le virus de l'hépatite B false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre la coqueluche false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anatoxine tétanique false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre Haemophilus influenzae de type B false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin inactivé contre la poliomyélite false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable Has manufactured dose form injection false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre la dipthérie false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Vaccin tétanos false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable Has manufactured dose form Solution for injection false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre la dipthérie false Inferred relationship Some 5
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre la coqueluche false Inferred relationship Some 3
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin inactivé contre la poliomyélite false Inferred relationship Some 4
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin contre Haemophilus influenzae de type B false Inferred relationship Some 1
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccin recombinant contre le virus de l'hépatite B false Inferred relationship Some 6
    Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Vaccin tétanos false Inferred relationship Some 2
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start